Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/04/2001 | US20010026932 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
10/04/2001 | US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets |
10/04/2001 | US20010026925 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
10/04/2001 | US20010026924 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
10/04/2001 | US20010026923 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
10/04/2001 | EP1144629A3 Further pro polypeptides and sequences thereof |
10/04/2001 | EP1139101A2 Immunoassay for c-reactive protein |
10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
10/04/2001 | EP1138771A1 Coffee endo-mannanase |
10/04/2001 | EP1138770A2 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
10/04/2001 | EP1138767A2 Disease resistance in vitis |
10/04/2001 | EP1138760A1 Neural cultures |
10/04/2001 | EP1137943A1 Cancer detection method and reagents |
10/04/2001 | EP1137810A2 A$g(b)-PEPTIDE SCREENING ASSAY |
10/04/2001 | EP1137808A1 Methods for making recombinant cells |
10/04/2001 | EP1137798A1 A method of isolating stem cells |
10/04/2001 | EP1137797A1 Expression system for factor viii |
10/04/2001 | EP1137796A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
10/04/2001 | EP1137791A2 Regulatory sequences of the mouse villin gene - use in transgenesis |
10/04/2001 | EP1137790A2 AN IMPROVED EFFICIENCY $i(AGROBACTERIUM)-MEDIATED PLANT TRANSFORMATION METHOD |
10/04/2001 | EP1137789A1 A method for manufacturing glycoproteins having human-type glycosylation |
10/04/2001 | EP1137787A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
10/04/2001 | EP1137783A2 Beta-1,3-galactosyltransferase homologs |
10/04/2001 | EP1137782A2 Method for regulating carotenoid biosynthesis in marigolds |
10/04/2001 | EP1137781A1 Mutants of rna polymerases with increased stability |
10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
10/04/2001 | EP1137775A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN |
10/04/2001 | EP1137774A2 Grnf4, a gdnf-related neurotrophic factor |
10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
10/04/2001 | EP1137768A1 Human hybrid host cell for mammalian gene expression |
10/04/2001 | EP1137767A1 Vectors having terminal repeat sequence of epstein-barr virus |
10/04/2001 | EP1137761A1 Cutinase variants |
10/04/2001 | EP1137757A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
10/04/2001 | EP1137756A2 Differentiation signal |
10/04/2001 | EP1137665A1 Cark protein and nucleic acid molecules and uses therefor |
10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
10/04/2001 | EP1137659A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
10/04/2001 | EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES |
10/04/2001 | EP1137656A1 31 human secreted proteins |
10/04/2001 | EP1137434A2 New cancer treatments |
10/04/2001 | EP0973800A4 Novel receptor |
10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
10/04/2001 | EP0784693B1 Viral vectors for gene therapy |
10/04/2001 | EP0772632B1 T cell stimulating protein of pestivirus |
10/04/2001 | EP0679256B1 Method to distinguish hematopoietic progenitor cells |
10/04/2001 | EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies |
10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
10/04/2001 | EP0413019B1 Synthetic plant genes and method for preparation |
10/04/2001 | DE10015985A1 Fluorescent tumor cells for studying gliomas in situ comprise cells from a tumor cell line that have been stably transfected with a gene or gene fragment encoding a fluorescent protein |
10/04/2001 | DE10012861A1 Rekombinante HHV8-DNA Recombinant HHV8 DNA |
10/04/2001 | CA2407036A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
10/04/2001 | CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
10/04/2001 | CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
10/04/2001 | CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
10/04/2001 | CA2404574A1 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/04/2001 | CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
10/04/2001 | CA2404563A1 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/04/2001 | CA2404533A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/04/2001 | CA2404528A1 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
10/04/2001 | CA2404496A1 Calcium binding regulatory subunit |
10/04/2001 | CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation) |
10/04/2001 | CA2404489A1 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
10/04/2001 | CA2404461A1 Human g-protein coupled receptors |
10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
10/04/2001 | CA2404417A1 Thermophilic polymerase iii holoenzyme |
10/04/2001 | CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/04/2001 | CA2404310A1 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
10/04/2001 | CA2404160A1 Identification of new human gaba transporter |
10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
10/04/2001 | CA2403829A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof |
10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
10/04/2001 | CA2403750A1 Human survivin interacting protein 1 (sip-1) |
10/04/2001 | CA2403637A1 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
10/04/2001 | CA2402780A1 Insulin and igf-1 receptor agonists and antagonists |
10/04/2001 | CA2402735A1 Human transcription factors |
10/04/2001 | CA2402613A1 Cationic liposomes |
10/04/2001 | CA2402453A1 Compounds for targeting |
10/04/2001 | CA2402098A1 Method for genetically modifying a plant |
10/04/2001 | CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
10/04/2001 | CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing |
10/04/2001 | CA2374911A1 G-protein coupled receptors |
10/03/2001 | CN1316009A Organisms for extracellular production of riboflavin |
10/03/2001 | CN1316007A Polynucleotide sequences |
10/03/2001 | CN1316006A Plants which synthesize modified starch, method for producing plants, their use and modified starch |
10/03/2001 | CN1316005A Nucleic acid molecule coding for beta-amylase, plants synthesizing modified starch, method of production and applications |
10/03/2001 | CN1316004A Method to screen herbicidal compounds utilizing air synthetase from Arabidopsis thaliana |
10/03/2001 | CN1316003A Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, method for production and use of said plants, and modified starch |
10/03/2001 | CN1316001A Polyketides and their synthesis |
10/03/2001 | CN1315999A Genetic method for expression of polyproteins in plants |
10/03/2001 | CN1315998A Compositions and methods for therapy and diagnosis of prostate cancer |
10/03/2001 | CN1315956A Polyketides and their synthesis |
10/03/2001 | CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
10/03/2001 | CN1315502A Cloned animal with recombined vital tissues and its culture process |